Effect of glucose concentration on peripheral nerve and its response to anoxia

Muscle and Nerve

Volumn 49, Issue 3, 2014, Pages 370-377

  Stecker, Mark M ^a   Stevenson, Matthew ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Anoxia; Diabetes; Glucose; Ischemia; Nerve conduction; Peripheral nerve

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANOXIA; ARTICLE; HYPERGLYCEMIA; HYPOGLYCEMIA; IN VITRO STUDY; NERVE FUNCTION; NERVE POTENTIAL; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANOXIA; DIABETES; GLUCOSE; ISCHEMIA; NERVE CONDUCTION; PERIPHERAL NERVE;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; BIOPHYSICS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GLUCOSE; NEURAL CONDUCTION; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SCIATIC NERVE; SWEETENING AGENTS;

EID: 84893909851     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23917     Document Type: Article

References (40)

1. Shi J, Xu J, Zhang X, Yang L. Positive feedback induced memory effect in ischemic preconditioning. J Theor Biol 2012;300317-323.
2. Karvestedt L, Martensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, et al. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabet Complic 2011;25:97-106.
3. Iizuka T. Effects of ischemia on peripheral nerve evoked potential. Experimental and clinical study. Nihon Seikeigeka Gakkai Zasshi 1984;58:307-322.
4. Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res 2011;39:366-377.
5. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012;6:CD007543.
6. Zangiabadi N, Shafiee K, Alavi KH, Assadi AR, Damavandi M. Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial. Minerva Endocrinol 2012;37:195-200.
7. Hernandez-Ojeda J, Cardona-Munoz EG, Roman-Pintos LM, Troyo-Sanroman R, Ortiz-Lazareno PC, Cardenas-Meza MA, et al. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study. J Diabet Complic 2012;26:352-358.
8. Hotta N, Kawamori R, Fukuda M, Shigeta Y, the Aldose Reductase Inhibitor-Diabetes Complications Trial Study Group. Treatment of long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med 2012;29:1529-1533.
9. Ramunno A, Cosconati S, Sartini S, Maglio V, Angiuoli S, La Pietra V, et al. Progresses in the pursuit of aldose reductase inhibitors: the structure-based lead optimization step. Eur J Med Chem 2012;51:216-226.
10. Bertolotto F, Massone A. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy. Drugs R D 2012;12:29-34.
11. Kawai T, Takei I, Tokui M, Funae O, Miyamoto K, Tabata M, et al. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(varepsilon)-carboxymethyl lysine. J Diabet Complic 2010;24:424-432.
12. Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic acid. Front Pharmacol 2011;2:69.
13. Lyzogub VH, Altunina NV, Bondarchuk OM. Application of alpha-lipoic acid in clinical practice. Lik Sprava 2011;:20-28.
14. Dellon AL, Muse VL, Nickerson DS, Akre T, Anderson SR, Barrett SL, et al. Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy. J Reconstr Microsurg 2012;28:241-246.
15. van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64:1348-1353.
16. Helgason CM. Blood glucose and stroke. Curr Treat Options Cardiovasc Med 2012;14:284-287.
17. Mitchell EA, Coates VE, Ryan AA, McCarron MO, Lyttle D, McCrum-Gardner E. Hyperglycaemia monitoring and management in stroke care: policy vs. practice. Diabet Med 2012;29:1108-1114.
18. Piironen K, Putaala J, Rosso C, Samson Y. Glucose and acute stroke: evidence for an interlude. Stroke 2012;43:898-902.
19. Petracek MR, Stevenson RL Jr, Lewis KB, Wright JR, Love JW. Effect of hyperglycemia on cardiac tolerance to normothermic anoxia arrest during cardiopulmonary bypass in dogs. Ann Surg 1970;172:1069-075.
20. Holman MC, Chidlow G, Wood JP, Casson RJ. The effect of hyperglycemia on hypoperfusion-induced injury. Invest Ophthalmol Vis Sci 2010;51:2197-2207.
21. Schneider U, Niedermeier W, Grafe P. The paradox between resistance to hypoxia and liability to hypoxic damage in hyperglycemic peripheral nerves. Evidence for glycolysis involvement. Diabetes 1993;42:981-987.
22. Weigl P, Bostock H, Franz P, Martius P, Muller W, Grafe P. Threshold tracking provides a rapid indication of ischaemic resistance in motor axons of diabetic subjects. Electroencephalogr Clin Neurophysiol 1989;73:369-371.
23. Grafe P, Bostock H, Schneider U. The effects of hyperglycaemic hypoxia on rectification in rat dorsal root axons. J Physiol 1994;480:297-307.
24. Strupp M, Jund R, Schneider U, Grafe P. Glucose availability and sensitivity to anoxia of isolated rat peroneal nerve. Am J Physiol 1991;261:E389-394.
25. Baylor K, Stecker MM. Peripheral nerve at extreme low temperatures 2: pharmacologic modulation of temperature effects. Cryobiology 2009;59:12-18.
26. Stecker MM, Baylor K. Peripheral nerve at extreme low temperatures 1: effects of temperature on the action potential. Cryobiology 2009;59:1-11.
27. Stecker M, Wolfe J, Stevenson M. Neurophysiologic responses of peripheral nerve to repeated episodes of anoxia. Clin Neurophysiol 2013;124:792-800.
28. Stecker M, Wolfe J, Stevenson M. Neurophysiologic responses of peripheral nerve to anoxia: effects of hypothermia and age. Clin Neurophysiol 2013;124:801-808.
29. Horlocker TT, Hebl JR, Gali B, Jankowski CJ, Burkle CM, Berry DJ, et al. Anesthetic, patient, and surgical risk factors for neurologic complications after prolonged total tourniquet time during total knee arthroplasty. Anesth Analg 2006;102:950-955.
30. Jacob AK, Mantilla CB, Sviggum HP, Schroeder DR, Pagnano MW, Hebl JR. Perioperative nerve injury after total hip arthroplasty: regional anesthesia risk during a 20-year cohort study. Anesthesiology 2011;115:1172-1178.
31. Kikkawa Y, Kuwabara S, Misawa S, Tamura N, Kitano Y, Ogawara K, et al. The acute effects of glycemic control on nerve conduction in human diabetics. Clin Neurophysiol 2005;116:270-274.
32. Saini AK, Arun KH, Kaul CL, Sharma SS. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine. Pharmacol Res 2004;50:593-599.
33. Kuwabara S, Ogawara K, Harrori T, Suzuki Y, Hashimoto N. The acute effects of glycemic control on axonal excitability in human diabetic nerves. Intern Med 2002;41:360-365.
34. Halonen JP, Ronnemaa T. Peripheral nerve conduction in healthy subjects during short-term hyperglycemia. Electromyogr Clin Neurophysiol 1998;38:355-358.
35. Kitano Y, Kuwabara S, Misawa S, Ogawara K, Kanai K, Kikkawa Y, et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 2004;56:462-467.
36. Sindrup SH, Ejlertsen B, Gjessing H, Svendsen A, Froland A. Peripheral nerve function during hyperglycemic clamping in insulin-dependent diabetic patients. Acta Neurol Scand 1989;79:412-418.
37. Parry GJ, Kohzu H. Acute changes in blood glucose affect resistance to ischemic nerve conduction failure. Neurology 1990;40:107-110.
38. Parry GJ, Kohzu H. Studies of resistance to ischemic nerve conduction failure in normal and diabetic rats. J Neurol Sci 1989;93:61-67.
39. Dyck PJ. Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture. Neurology 1989;39:111-118.
40. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 1996;55:1181-1193.